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Abstract
Hyperthermia is one of the most acute and life-threatening consequences of 3,4methylenedioxymethamphetamine (MDMA) use. The hyperthermia induced by MDMA
involves a complex interaction between heat generation and loss of heat dissipation.
Recent studies have demonstrated a role for gut microbiome in the regulation of body
weight and temperature. Here, we investigated the potential role of the gut microbiome
in MDMA-mediated hyperthermia. For fourteen days prior to treatment with MDMA (20
mg/kg, sc) male, Sprague-Dawley rats were provided regular drinking water or drinking
water laced with the non-absorbable antibiotics, bacitracin (0.5 mg/mL), neomycin
(2mg/mL), and vancomycin (0.2mg/mL). Antibiotic (ABX) treatment reduced gut
bacteria and increased cecal size. MDMA-induced a hyperthermic response that resulted
in a maximal temperature change (ΔTmax ) of 4.6 ± 0.1 °C and only a 50% survival rate
60 minutes after treatment. Conversely, ABX treatment prior to MDMA attenuated the
hyperthermic response with a ΔTmax of 3.4 ± 0.6 °C and a 100% survival rate 60 minutes
after treatment. An acute intraperitoneal injection of ABX 30 minutes before MDMA had
no effect on the hyperthermic response, eliminating the possibility of a
pharmacodynamics interaction between ABX and MDMA. Overall, these findings
demonstrate that the gut microbiome contributes to the hyperthermia mediated by
MDMA.

Introduction
3,4-Methylenedioxymethamphetamine (MDMA, Figure 1) is a synthetic drug more
commonly known as “Ecstasy” or “Molly.” Although MDMA was used for a short time
as an adjunct to psychotherapy in the 1970’s, illicit use of the drug did not become
popular until the emergence of the rave scene in the 1980’s (Dar and McBrien, 1996).
Like other substituted amphetamines, MDMA acts as a sympathomimetic agent
increasing norepinephrine levels centrally and peripherally (Sprague et al., 2007).
MDMA-induced hyperthermia has been associated with a combination of peripheral
vasoconstriction (Pedersen and Blessing, 2001) and activation of mitochondrial
uncoupling proteins (for a review, see Mills et al., 2003). Norepinephrine binds to the 𝛼1 adrenergeric receptor in vascular smooth muscle, resulting in vasoconstriction and
attenuated heat dissipation. MDMA induced release of norepinephrine also indirectly
activates uncoupling proteins (UCPs), through the release of free fatty acids (Mills et al.,
2007). When activated, UCPs dissipate the proton gradient across the inner mitochondrial
membrane, resulting in increased proton conductance and the release of energy as heat
(Cannon and Nedergaard, 2004). Free fatty acids in brown adipose tissue and skeletal
muscle mitochondria serve as ligand activators for UCP facilitated proton leak (Echtay et
al., 2001; Brand and Esteves, 2005). Zietak et al. (2016) demonstrated that changes in
intestinal microbiota and bile acids occur when ambient temperature is reduced, in
parallel with UCP induction. Skakun (1958) noted a marked increase in the total amount
of bile under the influence of amphetamine. Based on these studies and previous
knowledge of UCP-regulated thermogenesis, we hypothesize that intestinal bacteria may
play a role in MDMA-induced hyperthermia.

Results
Knockdown of Intestinal Bacteria using Non-Absorbable Antibiotics. To determine if
changes in intestinal microbiota influence the thermogenic responses to MDMA, animals
were given a cocktail of antibiotics, including bacitracin, neomycin, and vancomycin, via
their drinking water, for 14 days before MDMA treatment. Daily fluid intake and body
weight did not differ between groups over the course of the experiment. However,
prolonged treatment with antibiotics did result in markedly enlarged ceca (Fig. 2), as has
been previously described (Kiraly et al. 2016).
Effects of Gut Microbiota on MDMA-Induced Hyperthermia. Following the
subcutaneous (SC) administration of saline in both the antibiotic and water control
groups, core body temperature did not significantly change over the 60 min monitoring
period. MDMA significantly increased core body temperature in both the antibiotic and
water experimental groups at all time points compared to the two control groups (p
<0.0001, Fig. 3A). The ABX MDMA group showed a marked attenuated thermogenic
response compared to that of the H2O MDMA group (p=0.006, Fig. 3B). Total area under
the curve (TAUC) was also calculated, which provided additional evidence for the
diminished thermogenic responses of the ABX MDMA group when compared to the H2O
MDMA group (p=0.004, Fig. 3C). Additionally, only 50% of the control group treated
with MDMA survived after 60 min post-treatment, while the antibiotic group treated with
MDMA had a survivorship of 100% (Fig. 3D).
Acute Antibiotic Treatment. In order to confirm that the effects of the oral antibiotic
treatment on MDMA-induced hyperthermia were due to local actions within the gut and
not caused by a pharmacodynamics interaction between MDMA and the antibiotics, we

injected the animals with a single IP dose of antibiotics (1.67 mg/kg vancomycin, 20
mg/kg neomycin, and 293 U/kg bacitracin in PBS) thirty minutes before MDMA. These
animals did not display an attenuated thermogenic response to MDMA. Instead, these
animals displayed a similar maximum change in temperature as the control group
(p=0.4525, Fig. 4).
Discussion
In this study, we found that the depletion of gut microbiota resulted in a marked
attenuation of core body temperature in animals treated with MDMA. By 60 min postinjection, both the H2O MDMA and the ABX MDMA had displayed thermogenic
responses to the drug administration. However, the average core body temperature of the
control group treated with MDMA was about a full degree Celsius higher than that of the
ABX MDMA group, both at 60 min and 90 min post-treatment. Additionally, TAUC
analysis and ΔTmax information provided further evidence that the ABX MDMA
treatment group had a significantly smaller thermogenic response to MDMA
administration compared to that of the H2O MDMA treatment group. Together, this data
suggests that the host gut microbiome plays a role in the mechanism by which MDMA
mediates hyperthermia.

While this is the first study to directly examine the role of the gut microbiome in
MDMA-mediated hyperthermia, it is not the first to analyze the role of intestinal bacteria
in UCP-regulated thermogenesis. A previous study demonstrated that changes in ambient
temperature led to differences in gut microflora profiles, which directly affected UCPregulated thermogenesis and adiposity levels (Zietak et al., 2016). However, this study

did not utilize antibiotics to produce a marked change in the host gut microbiome. In our
study, we saw an attenuated thermogenic response to MDMA administration only when
antibiotics were given orally and thus were directly applied to the gut microbiota.
Intraperitoneal injections of the antibiotics did not lead to a significant decrease in core
rectal temperature, suggesting that it was the reduced gut bacteria that led to the
attenuated thermogenic response.

While the mechanism by which the host microbiome mediates MDMA-induced
hyperthermia remains unknown, we demonstrated here that there is a relationship
between these two biological systems. Although further work is needed to understand
these underlying mechanisms, our results help define potential routes for future research.
In particular, it will be important to define how alterations in the gut microbiome interact
with bile acids to modify MDMA-mediated hyperthermia. While much remains to be
discovered, there are potentially important therapeutic effects from these results,
including the identification of points of intervention in the development of acute
sympathomimetic-mediated hyperthermia. It could also lead to more personalized
medical treatments, tailored to an individual’s specific gut microbiome.

Methods
Animals. Male Sprague-Dawley Rats (284.6 ± 2.4g, Envigo, Indianapolis, IN) were
used. Animals were housed one per cage (21.0 × 41.9 × 20.3 cm3 ), maintained on a
12:12h light/dark schedule, and provided access to food and water ad libitum. Animals
were sustained on a minimum 10% fat diet and housed in a room kept at 24 − 26 ℃ in

order to maximize a thermogenic response (Mills et al., 2007, Dafters et al., 1994).
Animal maintenance and research were conducted in accordance with the eighth edition
of the Guide for the Care and Use of Laboratory Animals as adopted and circulated by
the National Institutes of Health, and protocols were approved by the Bowling Green
State University Animal Care and Use Committee. All animals were allowed to acclimate
to the facility for one week prior to the start of any treatments.
Study Design. Animals were randomly assigned to four treatment groups (n=6): H2O
Control, ABX Control, H2O MDMA, and ABX MDMA. Antibiotics were administered
via the drinking water for fourteen days in accordance with the methods described in the
study by Kiraly et al. (2016). Antibiotic doses were: Neomycin 2mg/mL, Vancomycin
0.2mg/mL, and Bacitracin 0.5 mg/mL. Fluid intake was measured daily and body weight
was measured every five days. On the fourteenth day, animals were injected
subcutaneously with either saline or MDMA (20 mg/kg). Temperatures were taken
rectally just prior to treatment (baseline) and every 30 min for an hour post-treatment,
using a Physiotemp Thermalert TH-8 termocouple (Physitemp Instruments, Clifton, NJ)
attached to a RET-2 rectal probe. The animals were then sacrificed and brown adipose
tissue (BAT), skeletal muscle tissue (SKM), and cecum were dissected out for qPCR
analysis of bacterial count (cecum), UCP 1&3 and TGR5 quantification (BAT and SKM).
In order to rule out the systemic effects of the antibiotics, animals were injected
intraperitoneally with 1.67 mg/kg vancomycin, 20 mg/kg neomycin, and 293 U/kg
bacitracin in PBS (Kiraly et al. 2015) thirty minutes before the administration of MDMA
(20 mg/kg). Temperatures were taken rectally just prior to antibiotic administration
(baseline) and every 30 minutes for an hour post-treatment of MDMA.

Statistical Analysis. GraphPad InStat v.6.0 software was used to complete all statistical
analyses of data. Temperatures between treatment groups were compared using one-way
ANOVA with a Student-Newman-Keuls post-hoc test. Additionally, temperatures within
a treatment group were compared using a one-way ANOVA with a Dunnett’s post-hoc
test. Maximum temperature change (ΔTmax) was calculated by comparing the maximum
increase in core temperature to the animal’s baseline temperature. An unpaired, twotailed t-test was used to compare the maximum temperature changes between the ABX
MDMA and H2O MDMA groups. Significance was set at the 95% confidence level (p
<0.05).
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Figure 1. Chemical structure of 3,4-methylenedioxymethamphetamine (MDMA).
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Figure 2. Daily fluid intake for both antibiotic-treated (ABX) and control
(H2O) groups (A). Mean body weight for both antibiotic-treated and control
groups (B). Gross histology of the cecum from control (left) and antibiotictreated (right) animals (C).
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Figure 3. Changes in core temperature following the administration of MDMA (A).
Maximum change in temperature following the administration of MDMA (B).
Temperature-area under the curve (TAUC) following the administration of MDMA
(C). Animal survivorship following the administration of MDMA (D). * indicates
significant difference from all other treatment groups (p<0.05).

Figure 4

Figure 4. Maximum change in temperature following intraperitoneal
administration of antibiotics.
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